News

Sandoz, a Novartis division and the pioneer and global leader in biosimilars, announced that the European Commission (EC) granted marketing authorization for biosimilar Ziextenzo …
Read More...

Jecure Therapeutics Inc., a biotechnology company with novel drug discovery programs targeting serious inflammatory diseases, announced a definitive agreement by which it will be…
Read More...

AiPing Pharmaceutical, Inc. announced that it has completed the sale of three ibuprofen Abbreviated New Drug Applications (ANDAs) in the U.S. to Shandong Xinhua Pharmaceutical Co., Ltd.…
Read More...

Octapharma announced that the Swiss Agency for Therapeutic Products, Swissmedic, granted marketing authorization to its new fibrinogen concentrate product fibryga for the treatment of…
Read More...

CBT Pharmaceuticals (CBT) and Zhejiang Bossan Pharmaceutical Co., Ltd (Bossan) announced that they have entered into a clinical collaboration and license agreement to develop their…
Read More...

Edge Therapeutics and PDS Biotechnology Corporation announced that their respective boards of directors have approved a definitive merger agreement. The merger is expected to create a…
Read More...

Telix Pharmaceuticals Limited has announced the acquisition of Belgium-based Advanced Nuclear Medicine Ingredients (ANMI) SA for €5.15m in cash and shares. The acquisition of ANMI…
Read More...

Fusion Antibodies plc, experts in antibody engineering and Analytics Engines, an advanced data analytics company, have announced a strategic collaboration to incorporate machine…
Read More...

Vir Biotechnology, Inc. and Alnylam Pharmaceuticals, Inc. announced the initiation of a Phase 1/2 study of VIR-2218, a novel, investigational RNA interference (RNAi) therapeutic for the…
Read More...

Machavert Pharmaceuticals, a drug development company focused on bioactive phospholipid therapeutics for the treatment of cancer, recently reported impressive preclinical results. The…
Read More...

AstraZeneca announced that the US Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) for Fasenra (benralizumab) for the treatment of Eosinophilic…
Read More...

The Mundipharma network of independent associated companies announced that the European Commission (EC) has granted approval for the use of Pelmeg (pegfilgrastim) as a treatment for…
Read More...

Shanghai Roche Pharmaceuticals and Ascletis BioScience jointly announce that starting from 1st Dec 2018, Ascletis and Roche will expand their partnership in viral Hepatitis. Following…
Read More...

Danish dermatology specialists LEO Pharma and California rare disease pioneers PellePharm announced a strategic development and commercialization collaboration to address unmet medical…
Read More...

OBI Pharma, Inc., a Taiwan biopharma company announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation for OBI-888 for the treatment of Pancreatic…
Read More...

WuXi Biologics announced that construction of a global innovation center has commenced in the district of Fengxian in Shanghai. The new state-of-the-art biologics center will…
Read More...

Rare cancers inherently make it difficult to collect data, build clinical expertise and treat affected patients – challenges which are best addressed through collaboration in…
Read More...

Ligand Pharmaceuticals Incorporated announces it has entered into a worldwide OmniAb partnership with iMetabolic Biopharma Corporation (iMBP), an early stage biopharma company located…
Read More...

HitGen Ltd announced that the company has entered into a drug discovery research collaboration with Biogen to identify novel small molecule leads for targets of interest. In this…
Read More...

Evotec AG announced that it has entered into a research collaboration with Immuneering Corporation (“Immuneering”), a worldwide leader in data-driven drug discovery, to discover novel…
Read More...